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Introduction:  Chronic  Critical  Illness  (chronic  CI)  is  a  condition  associated  to  patients  surviving
an episode  of  acute  respiratory  failure  (ARF).  The  prevalence  and  the  factors  associated  with
the development  of  chronic  CI  in  the  population  admitted  to  a  Respiratory  Intensive  Care  Unit
(RICU) have  not  yet  been  clarified.
Methods:  An  observational  prospective  cohort  study  was  undertaken  at  the  RICU  of  the  Univer-
sity Hospital  of  Modena  (Italy).  Patients  mechanically  ventilated  with  ARF  in  RICU  were  enrolled.
Demographics,  severity  scores  (APACHEII,  SOFA,  SAPSII),  and  clinical  condition  (septic  shock,
pneumonia,  ARDS)  were  recorded  on  admission.  Respiratory  mechanics  and  inflammatory-
metabolic blood  parameters  were  measured  both  on  admission  and  over  the  first  week  of  stay.Tracheostomy All variables  were  tested  as  predictors  of  chronic  CI  through  univariate  and  multivariate  analysis.
Results:  Chronic  CI  occurred  in  33  out  of  100  patients  observed.  Higher  APACHEII,  the  pres-
ence of  septic  shock,  diaphragmatic  dysfunction  (DD)  at  sonography,  multidrug-resistant  (MDR)
bacterial  infection,  the  occurrence  of  a  second  infection  during  stay,  and  a  C-reactive  protein
Abbreviations: ARDS, acute respiratory distress syndrome; ARF, acute respiratory failure; Chronic CI, chronic critical illness; CRP, C
reactive protein; MDR, multidrug-resistant; MV, mechanical ventilation; NIV, non-invasive mechanical ventilation; RICU, respiratory intensivePlease  cite  this  article  in  press  as:  Marchioni  A,  et  al.  Pulmonol.  2019.  https://doi.org/10.1016/j.pulmoe.2019.09.006
care unit; RR, relative risk; DD, diaphragm dysfunction.
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(CRP)  serum  level  inceasing  7  days  over  admission  were  associated  with  chronic  CI.  Septic  shock
was the  strongest  predictor  of  chronic  CI  (AUC  =  0.92  p  <  0.0001).
Conclusions:  Chronic  CI  is  frequent  in  patients  admitted  to  RICU  and  mechanically  ventilated
due to  ARF.  Infection-related  factors  seem  to  play  a  major  role  as  predictors  of  this  syndrome.
© 2019  Published  by  Elsevier  Espan˜a,  S.L.U.  on  behalf  of  Sociedade  Portuguesa  de  Pneumologia.
















































































n  recent  years,  life  support  techniques  have  improved  the
utcomes  of  patients  with  acute  respiratory  disorders,  but
ave  also  led  to  the  emergence  of  a  population  of  survivors
ven  though  dependent  on  mechanical  ventilation  (MV),  the
o  called  ‘‘chronically  critical  ill-chronic  CI’’.1
In  western  countries,  chronic  CI  is  rapidly  growing  and
t  is  associated  with  increased  number  of  days  in  the  inten-
ive  care  unit  (ICU),  prolonged  hospitalization  in  post-acute
weaning)  centers,  and  poor  prognosis  in  the  long  term.2
round  50%  of  patients  developing  chronic  CI  die  within  6
onths  following  discharge  from  ICU,  while  only  10%  of  sur-
ivors  return  home  with  autonomy.3,4
The  clinical  features  of  these  patients  are  consistent
nough  to  define  chronic  CI  as  a  syndrome  characterized
y  neuroendocrine  changes,  alteration  of  body  composi-
ion,  neurological  modifications,  malnutrition  and  muscle
asting.5--7 However,  an  exhaustive  definition  of  chronic  CI
s  still  not  available.  A  recent  consensus  definition  resulted
rom  the  combination  of  two  factors:  care  received  in  ICU
or  at  least  8  days,  and  at  least  one  out  of  five  eligible  con-
itions  (MV  prolonged  >96  h;  tracheostomy;  sepsis  or  other
evere  infections;  severe  wounds  and/or  multiple  organ
ailure;  ischemic  stroke,  intercerebral  hemorrhage  or  trau-
atic  brain  injury),  prolonged  MV  and  tracheostomy  were
he  two  reliable  indicators  of  chronic  CI  occurring  in  patients
ith  acute  respiratory  failure  (ARF).8,9
Although  chronic  CI  is  described  in  the  whole  popula-
ion  of  patients  admitted  to  ICUs,10--12 there  are  still  no
tudies  focusing  on  those  patients  suffering  from  de  novo
RF  following  conditions  with  a  vigorous  local  and  systemic
nflammatory  response,  such  as  pneumonia  and  Acute  Res-
iratory  Distress  Syndrome  (ARDS).13,14
Primary  aim  of  this  study  was  to  describe  the  prevalence
nd  the  development  of  chronic  CI  in  a  population  of  patients
ith  de  novo  ARF  admitted  to  a  specialized  RICU.  The  asso-
iation  between  clinical  and  mechanical  features  and  the
evelopment  of  chronic  CI  was  investigated  as  secondary
utcome.
aterials and methods
tudy  populationPlease  cite  this  article  in  press  as:  Marchioni  A,  et  al.  Pulmono
his  prospective  observational  cohort  study  was  carried  out
n  a  single  6-bed  RICU  at  the  University  Hospital  of  Mod-




j018).  Written  informed  consent  to  participate  was  obtained
rom  all  patients  enrolled  or  their  relatives.  Approval  was
btained  from  the  local  ethics  committee  of  Modena  (pro-
ocol  839/C.E.  and  266/16  C.E.),  and  the  trial  was  registered
t  clinicaltrials.gov  (NCT03851822).
Eligible  patients  >18  years  of  age  were  those  consec-
tively  admitted  to  the  RICU  due  to  ARF  (hypoxemia  or
ypoxemia  with  hypercapnia)  requiring  MV,  and  with  a  stay
8  day.  Exclusion  criteria  were:  1)  refractory  shock,  2)
atient  goals  of  care  not  consistent  with  aggressive  mana-
ement,  3)  end-stage  chronic  obstructive  pulmonary  disease
COPD)  requiring  home  oxygen  and/or  ventilatory  support,
)  interstitial  lung  disease,  5)  neuromuscular  disease,  6)
hest  wall  deformities,  7)  pregnancy,  8)  chemotherapy  or
adiotherapy  during  the  past  30  days,  9)  brain  injury  on  CT
can  and/or  Glasgow  Coma  Scale  (GCS)  score  <8,  10)  tra-
heostomy.  All  patients  were  treated  according  to  the  best
urrent  clinical  practice  by  the  attending  staff,  unaware  of
he  study  purpose.  All  patients  were  provided  with  mobiliza-
ion  and  rotation  on  a  daily  basis.
eneral  measurements
emographics,  severity  scores,  namely  the  Kelly-Matthay
cale,  the  Acute  Physiology  and  Chronic  Health  Evaluation  II
APACHE  II),  the  Simplified  Acute  Physiology  Score  (SAPS  II),
nd  the  Subsequent  Organ  Failure  Assessment  (SOFA)  were
ecorded  at  admission.  Presence  of  ARDS,  pneumonia  or
eptic  shock  was  assessed  at  baseline  whereas  pre-existing
omorbidities  were  reported  through  the  Charlson  Comor-
idity  Index;  concomitant  COPD  had  to  be  confirmed  by
oth  smoking  habit,  past  medical  history,  non-reversible
bstruction  at  spirometry  performed  in  the  year  before.
ospitalizations  in  the  previous  6-month  were  also  reported.
Arterial  blood  gases  (PaO2,  PaCO2),  pH,  and  PaO2/FiO2
atio  were  recorded  at  baseline;  blood  procalcitonin,  glu-
ose,  albumin,  creatinine  and  lactate  were  measured  at
aseline  and  after  1,  2  and  7  days  following  admission.
ultidrug-resistant  (MDR)  microorganism  colonization  and
nfection,  and  the  onset  of  a  second  infection  during  RICU
tay  were  recorded.
ung  mechanicsl.  2019.  https://doi.org/10.1016/j.pulmoe.2019.09.006
 subset  of  patients  under  MV  as  divided  into  two  groups
ccording  to  the  ventilatory  mode  (assisted  spontaneous
reathing  ----  ASB,  and  controlled  ventilation-CMV)  was  sub-
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Patients  in  the  ASB  group  underwent  esophageal  pres-
sure  (Pes)  and  transpulmonary  pressure  (PL)  monitoring
performed  through  a  nasogastric  tube  (NutriVent  nasogas-
tric  polyfunctional  catheter;  SIDAM,  Mirandola,  Italy)  with  a
pressure  transducer  (OptiVent  monitor,  SIDAM)  and  accord-
ing  to  a  standard  procedure.15,16 PL  was  calculated  as  airway
pressure  (Paw)  -- Pes.  In  order  to  avoid  using  absolute  val-
ues  for  Pes  and  PL,  we  always  referred  to  Pes  and  PL
from  the  end-expiratory  level,  respectively.  The  waveforms
of  Paw,  Pes  and  airflow  were  continuously  recorded  using
a  data  acquisition  system  (PowerLab;  AD  Instruments,  Col-
orado  Springs,  CO,  USA)  at  a  sampling  frequency  of  100  Hz
for  offline  data  analysis.17
Patients  in  the  CMV  group,  underwent  ventilation  set  in
control  mode  with  a  Vt  =  6  ml/kg  and  positive  end-expiratory
pressure  (PEEP)  adjusted  on  the  basis  of  the  incremental
FiO2/PEEP  combinations.18 Measurements  of  static  respira-
tory  mechanics  were  performed  after  30  min  of  constant
flow  during  MV.  The  values  of  pressure  were  obtained  dur-
ing  baseline  ventilation  with  an  airway  occlusion  at  the
end  of  inspiration  pressing  the  end-inspiratory  hold,  until
reaching  a  plateau  pressure,  and  subsequently  performing
a  similar  procedure  with  an  end-expiratory  occlusion.  Dur-
ing  the  procedure,  occlusions  that  did  not  produce  a  clear
plateau  were  discarded.  Airway  driving  pressure  (Paw)  was
defined  as  the  end-inspiratory  plateau  pressure  (Pplat)  ----
positive  end-expiratory  airway  pressure  (PEEPtot).  All  these
measurements  were  performed  within  24  h  from  MV  start.
Diaphragmatic  function
Ultrasound  (US)  of  the  diaphragm  was  assessed  on  both
sides  at  admission  during  spontaneous  breathing.  Motility
of  the  diaphragm  was  assessed  at  the  bedside  in  the  semi-
recumbent  position  by  a  B-mode  US  device  (GE  Vivid  7;  GE
Healthcare  Life  Sciences,  Helsinki,  Finland)  connected  to  a
7--12  MHz  linear  probe  as  previously  reported.19 Thickening
fraction  (TF)  during  spontaneous  breathing19 was  calcu-
lated  as:  Tdi  = (end-inspiration  Tdi  --  end-expiration  Tdi/
end-expiration  Tdi)  ×  100.  The  best  value  of  three  mea-
surements  was  taken  as  representative  of  the  diaphragm
function  and  then  recorded  for  analysis.
Definitions  and  outcomes
Diaphragm  dysfunction  (DD)  was  defined  according  to  the
presence  of  TF  bilaterally  lower  than  20%.19
Survivors  with  both  hospital  stay  >8  days  and  with  tra-
cheostomy  due  to  a  need  of  MV  >  21  consecutive  days  for
at  least  6  h/day  were  defined  as  having  chronic  CI.1 The
prevalence  of  chronic  CI  was  the  primary  aim  of  this  study.
According  to  the  Berlin  definition,  patients  were  consid-
ered  as  having  ARDS  if  they  had:  [1]  acute  respiratory  failure
not  fully  explained  by  cardiac  failure  or  fluid  overload;  [2]
bilateral  opacities  consistent  with  pulmonary  edema  on  the
chest  radiograph  or  the  computed  tomography  scan;  and
[3]  onset  within  1  week  after  a  known  clinical  insult  orPlease  cite  this  article  in  press  as:  Marchioni  A,  et  al.  Pulmono
new/worsening  respiratory  symptoms.20 Septic  shock  was
present  according  to  the  onset  of  sepsis  with  require-
ment  of  vasopressor  to  maintain  a  mean  arterial  pressure




ory  failure.  3
n  the  absence  of  hypovolemia.21 Multi-Drug-Resistant  (MDR)
nfection  was  defined  as  the  presence  of  sepsis  with  blood
solation  of  a  MDR  bacterial  agent.  The  onset  of  a  second
nfection  was  defined  by  the  occurrence  of  clinical,  radiolog-
cal  and  microbiological  signs  of  infection  during  RICU  stay
after  at  least  2  days  of  stability  when  recovering  from  the
rst  episode).  The  association  between  chronic  CI  and  demo-
raphics,  inflammatory  and  metabolic  blood  parameters
C-reactive  protein-CRP,  sepsis  and  septic  shock,  infection
nd  MDR  bacterial  infection),  and  respiratory  mechanics
transpulmonary  and  driving  pressure)  on  admission  and/or
heir  trends  between  days  1  and  7,  were  considered  as  sec-
ndary  outcomes  of  the  study.
tatistical  analysis
he  statistical  package  GraphPad  Prism  7.0  (GraphPad  Soft-
are,  Inc.,  La  Jolla,  CA,  USA)  was  used  for  statistical
nalysis.  Initially,  we  performed  a  power  test  (  =  0.05,
ower  80%)  considering  a  prevalence  of  up  to  20%  of  patients
ndergoing  MV  for  >48  h and/or  tracheostomy  in  the  criti-
al  care  area,7 and  an  average  annual  mortality  rate  of  24%
mong  patients  admitted  to  RICU  and  requiring  MV.  A  sam-
le  size  of  127  patients  was  required  to  confidently  perform
nalysis  on  the  pre-specified  primary  scope  of  our  study.
The  considered  variables  were  investigated  through  uni-
ariate  analysis  and  contingency  table  analysis  for  relative
isks  to  detect  the  possible  risk  factors  associated  with
hronic  CI  once  in  RICU.
Significant  variables  then  entered  a  multivariate  regres-
ion  analysis,  with  a  backward  stepwise  method  to  exclude
on-significant  variables  from  the  model.  Independent  varia-
les  able  to  predict  chronic  CI  at  the  multivariate  test  were
hen  entered  intoa  ROC  analysis.
A p-value  lower  than  0.05  was  considered  to  be  statisti-
ally  significant.
esults
n  the  period  considered,  127  patients  were  found  to  be
ligible;  27  out  of  the  127  subjects  died  in  RICU  and  were
xcluded  from  the  analysis  (see  Fig.  1).
Thirty-three  patients  (33%)  developed  chronic  CI  during
tay  in  RICU.  Table  1  shows  demographics,  biochemistry,
linical  and  physiological  characteristics  of  patients  devel-
ping  chronic  CI  (n  =  33)  as  compared  with  others  (n  =  67).
auses  of  de  novo  ARF  included  acute  exacerbation  of  COPD
n  =  45),  septic  shock  (n  =  19),  pneumonia  (n  =  10),  pulmonary
mbolism  (n  =  10),  ARDS  (n  =  7  [pulmonary  infection  driven
 =  5,  extra-pulmonary  infection  driven  =  2]),  acute  exacer-
ation  of  asthma  (n  =  5),  lung  inhalation  (n  =  4).  In  the  subset
f  patients  undergoing  lung  mechanical  assessment,  PL
nd  Paw  were  not  associated  with  chronic  CI.  The  trend
f  CRP  levels,  but  not  other  blood  parameters,  over  1-week
rom  admission  was  different  when  comparing  patients  with
r  without  chronic  CI  (p  =  0.037,  Fig.  2).
Table  1  also  shows  the  results  from  the  univariate  andl.  2019.  https://doi.org/10.1016/j.pulmoe.2019.09.006
he  multivariate  analysis  performed  to  identify  potential
redictors  of  chronic  CI  development  in  the  study  cohort.
Higher  APACHE  II  score  on  admission,  the  presence  of







































Table  1  Demographics,  clinical  and  physiological  variables  in  the  study  population,  univariate  and  multivariate  analysis  of  variables  as  potential  risk  factors  for  developing
critical care  illness  in  the  population  in  this  study.
Outcome  Total  =  100  (100)  Chronic  CI  =  33  (33)  No-CI  =  67  (67)  Univariate  analysis  Multivariate  analysis
Relative  Risk  (95%CI)  p  value  Relative  Risk  (95%CI)  p  value
Age  (years)  69.  8  (8.6)  66.1  (6.9)  72  (10.2)  0.76  (0.34--1.29)  n.s  (0.09)
Male sex  (n)  51  (51)  20  (61)  31  (46)  1.2  (0.43--1.9)  n.s.  (0.76)
BMI 24.5  (6.5)  25.6  (4.5)  24.2  (6.9)  1.4  (0.65--2.1)  n.s.  (0.54)
Kelly score  2.3  (1.5)  2.5  (1.3)  2.2  (1.6)  1.67  (0.87--2.3)  n.s  (0.08)
APACHE II  score  23.4  (9.7)  30.1  (12.6)  19.9  (9)  3.5  (1.6--8.2)  <0.001  3.5  (1.2--7.4)  0.002
SAPS II  score  39.5  (16.5)  47.3  (18.6)  35  (14.5)  3.9  (1.1--10.3)  0.002
SOFA score  6.1  (2.5)  7.36  (1.6)  5.4  (2.7)  2.9  (1.2--5.3)  0.01
Charlson index  2.7  (2)  3.1  (2.5)  2.4  (1.8)  1.5  (0.67--3.5)  n.s.  (0.18)
Presence of  COPD  (n)  61  (61)  21  (63)  40  (60)  1.5  (0.85--2.6)  n.s.  (0.24)
Pneumonia (n)  10  (10)  4  (12)  6  (9)  1.1  (0.35--3.3)  n.s.  (0.9)
Septic shock  (n)  19  (19)  17  (52)  2  (3)  14  (4--37)  <0.0001  7.2  (2--19)  <0.001
ARDS (n)  7  (7)  2  (6)  5  (7.5)  0.7  (0.55--2.7)  n.s.  (0.7)
PL (cmH2O)  23.7  (14.2)  24  (12.4)  23.6  (15.1)  0.85  (0.67--4.9)  n.s.  (0.85)
Paw (cmH2O)  9  (6.5)  10.7  (7.7)  8  (4.9)  1.6  (0.67--2.6)  n.s.  (0.7)
TF <  20%  17  (17)  13  (39.4)  4  (6)  3.17  (1.9--4.9)  <0.0001  3.7  (1.1--6.9)  0.003
C reactive  protein  (mg/dl)  14  (13.4)  9.7  (8.5)  18.5  (14.6)  0.4  (0.1--1.7)  n.s.  (0.08)
Procalcitonin (ng/L)  8.6  (5.5)  14.4  (4.2)  6.9  (6.2)  1.8  (0.67--5.9)  n.s.  (0.25)
Glucose (mg/dL)  155  (45)  156  (37)  154.7  (49)  1  (0.80--1.3)  n.s.  (0.9)
Albumin (mg/dL)  3  (1.7)  2.9  (1.5)  3.1  (1.9)  1.7  (0.78--2.56)  n.s.  (0.15)
Creatinine (mg/l)  1.29  (0.8)  1.3  (0.76)  1.27  (0.9)  1.1  (0.77--1.9)  n.s.  (0.44)
Lactate (mg/dL)  17  (10)  22.34  (12)  14.2  (9)  3.5  (0.8--9.2)  n.s.  (0.07)
pH 7.33  (0.1)  7.29  (0.12)  7.36  (0.1)  2.9  (0.91--6.7)  n.s.  (0.06)
P/F ratio  189  (55)  206  (61)  165  (52)  1.4  (0.7--2-3)  n.s.  (0.32)
Arterial pCO2 60  (11)  66.6  (14)  56  (9)  3.4  (0.81--6.7)  n.s.  (0.09)
Recent hospitalizationa (n)  29  (29)  15  (45)  14  (21)  1.8  (1--3.6)  n.s.  (0.06)
Multidrug resistant  (MDR)
micro-organism  colonization
26  (26)  13  (39)  13  (20)  1.7  (0.9--3.2)  n.s.  (0.14)
MDR infection  12  (12)  9  (27)  3  (4.5)  4.7  (1.6--13)  0.009  4.7  (1.3--9)  0.021
Second infection  during  RICU  stay  33  (33)  17  (52)  16  (24)  3.17  (1.1--3.1)  0.031  1.9  (1.1--4.5)  0.027
CRP worsening  (n)  33  (33)  17  (52)  16  (24)  3.1  (2--8.1)  0.006  2.1  (1.4--6.1)  0.036
Data are presented as number and percentage for dichotomous values or mean value and standard deviation for continuous values.
a Within 6 months.
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Figure  1  Description  of  the  study  population.
ARF  =  acute  respiratory  failure,  MV  =  mechanical  ventilation,
RICU =  Respiratory  Intensive  Care  Unit,  LTOT  =  Long  Term
Oxygen  Therapy,  NIV  =  Non  Invasive  Mechanical  Ventilation,
ILD =  Interstitial  Lung  Disease,  CT  =  Computed  Tomography,
GCS =  Glasgow  Coma  Scale,  ASB  =  Assisted  Spontaneous  Breath-
ing, PL  =  Transpulmonary  Pressure,  CMV  =  Controlled  Mechanical































































































pathobiological  hypothesis  underlying  PICS  development.Figure  2  Time  course  of  CRP  serum  level  in  patients  devel-
oping  chronic  CI  or  recovering.
ond  infection  during  stay,  and  a  trend  of  CRP  to  increase  at
day  7  after  admission  were  independently  associated  with
chronic  CI  development;  ROC  analysis  indicated  that  septic
shock  was  the  strongest  predictor  (AUC  =  0.92,  p  <  0.0001)  of
chronic  CI  onset  (see  Fig.  3).
Discussion
With  this  cohort  study,  we  have  observed  a  33%  preva-
lence  of  chronic  CI  in  patients  admitted  to  RICU  due  to  dePlease  cite  this  article  in  press  as:  Marchioni  A,  et  al.  Pulmono
novo  ARF.  We  have  also  shown  that  a  worse  clinical  severity
and  diaphragmatic  dysfunction  at  admission,  early  worsen-
ing  of  systemic  inflammation,  type  of  infection,  and  septic
P
s
aigure  3  ROC  analysis  comparing  predictors  of  chronic  CI.
UC =  Area  under  the  curve.
hock  in  particular,  are  factors  independently  associated
ith  chronic  CI  development.
revalence  of  chronic  CI  in  the  ICU
iven  the  lack  of  a  univocal  definition  of  chronic  CI,  the
xact  prevalence  of  this  condition  remains  unknown.  As
 whole  in  patients  admitted  to  ICUs,  the  prevalence  of
hronic  CI  defined  as  the  need  to  prolong  MV  is  around
0%.1 Moreover,  chronic  CI  represents  a  predominant  clin-
cal  feature  in  up  to  50%  of  patients  who  survive  an  episode
f  sepsis.10 In  our  study  performed  in  a  medical  special-
zed  ICU  in  patients  with  de  novo  ARF,  onset  of  chronic  CI
as  lower  than  that  reported  in  a  surgical  ICU.10 However,
n  the  latter  study10 the  definition  of  chronic  CI  referred
o  the  length  of  stay  in  ICU  for  ≥14  days  with  persistent
rgan  dysfunction  as  assessed  by  SOFA  score.  In  our  study,
hronic  CI  was  defined  as  the  need  for  respiratory  intensive
are  for  ≥8  days  associated  with  the  decision  to  perform
racheostomy  and  to  prolong  MV.  Prolonged  mechanical  ven-
ilation  and  tracheostomy  are  factors  that  increase  per  se
he  risk  of  bed-lying,  thus  requiring  combined  strategies  to
void  complications  and  speed-up  recovery  in  specialized
ntensive  care  settings.22
nflammation  and  chronic  CI
uring  stay  in  ICU,  persistence  of  inflammatory  state
s  the  pathophysiological  key  which  may  favor  chronic
I  development.23 The  term  ‘‘persistent  inflammation,
mmunosuppression  and  catabolism  syndrome’’  (PICS)  has
een  coined  to  describe  a  phenotype  of  chronic  CI
n  surgical  ICU  patients  who  suffered  from  major  pro-
nflammatory  event  (blunt  traumatic  injury/sepsis).24,25 A
elf-perpetuating  cycle  of  inflammation  constitutes  the
26l.  2019.  https://doi.org/10.1016/j.pulmoe.2019.09.006
atients  who  develop  chronic  CI  after  sepsis  exhibit  per-
istent  elevations  of  systemic  inflammatory  cytokines  (IL-6
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he  case  of  the  inflammatory  response  during  ARDS.27 Per-
istence  of  elevated  levels  of  inflammatory  cytokines  and
hemokines  in  circulating  fluids  and  bronchoalveolar  lavage,
ould  lead  patients  with  ARF  to  chronic  CI.28 In  patients
ith  ARDS,  longitudinal  sampling  has  proved  that  local  and
ystemic  inflammation  may  persist  for  several  weeks,  even
fter  the  resolution  of  the  respiratory  syndrome.29 Recently,
oth  hyperinflammatory  and  hypoinflammatory  subpheno-
ypes  were  identified  analyzing  biomarkers  plasma  levels
rom  two  trials  in  patients  with  ARDS.30 The  hyperinflam-
atory  subphenotype  is  characterized  by  fewer  days  free
rom  ventilatory  and/or  organ  failure,  conditions  which
onstitute  a  risk  factor  for  chronic  CI.  In  our  study,  the  mea-
urement  during  the  first  week  after  admission  of  CRP  as  a
arker  of  inflammation  was  able  to  distinguish  the  group  of
atients  who  would  develop  chronic  CI  from  those  who  did
ot  and  would  recover  (Fig.  2).
nfection  and  chronic  CI
o  study  the  underlying  mechanisms  that  drive  chronic
I  progression  over  the  course  of  sepsis,  different  ani-
al  models  and  clinical  studies  in  survivors  have  been
onducted.30--32 Data  show  that  immunological  dysfunction
nd  repeated  infections  have  a  role  in  maintaining  inflam-
ation  and,  finally,  trigger  chronic  CI.33,34 In  line  with  these
ndings,  our  study  confirms  that  patients  with  ARF  present-
ng  a  second  infection  during  stay  in  RICU  or  having  a  MDR
acterial  infection  are  more  likely  to  develop  chronic  CI.
verall,  this  suggests  that  immunological  dysregulation  and
usceptibility  to  infection  constitute  a  mechanism  favor-
ng  the  development  of  chronic  CI  in  these  individuals.
nterestingly,  septic  shock,  a  condition  characterized  by  pro-
ound  circulatory,  cellular  and  metabolic  alterations,  was
he  strongest  predictor  of  chronic  CI  development  in  our
tudy  (Fig.  3).
D  and  chronic  CI
n  patients  suffering  from  acute  critical  illness  of  various
tiologies,  respiratory  muscle  dysfunction  is  quite  frequent
nd  may  develop  early.  Demoule  et  al.  have  shown  that  64%
f  patients  admitted  to  ICU  have  DD  at  the  acute  onset,
epsis  being  the  major  independent  risk  factor.35 The  mech-
nisms  underlying  sepsis-induced  DD  (SIDD)  are  complex.36
t  the  molecular  level,  there  is  evidence  that  cytokines
TNF-alpha,  IL-1alpha,  IL-1beta  and  IL-6)  and  inflammatory
ignaling  (NF-kappaB  pathways)  are  involved,37 and  may  pro-
ote  mitochondrial  dysfunction,  reactive  oxygen  species
ROS)  production,  and  breakdown  of  sarcomere  proteins  dur-
ng  infection.38 In  the  present  study,  we  have  reported  that
D  (i.e.  TF  <  20%)  by  noninvasive  assessment  early  at  the
ime  of  admission  is  a  risk  factor  in  the  specific  population
f  difficult-to-wean  patients.  To  the  best  of  our  knowledge,
his  result  is  new  and  opens  further  research  perspectives.Please  cite  this  article  in  press  as:  Marchioni  A,  et  al.  Pulmono
entilatory  induced  lung  injury  and  chronic  CI
here  is  evidence  in  literature  that  indicates  that  MV  plays  a
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icular,  non-physiological  stress/strain  could  act  as  a  trigger
nd  amplifier  for  local  and  systemic  inflammation.40 In  our
tudy,  we  measured  Paw  as  a surrogate  marker  for  cyclic
ung  strain  in  patients  receiving  ventilator  support41 and  PL
s  a  marker  of  lung  stress  in  patients  with  ASB16;  however,  we
ailed  to  find  any  correlation  with  chronic  CI  development.
herefore,  even  though  lung  mechanics  have  been  used  with
 small  group  of  patients,  data  suggest  that  mechanical
tress/strain  on  lung  parenchyma  might  play  only  a  minor
ole  in  the  physiopathology  behind  the  onset  of  chronic  CI.
imitations
espite  intriguing  findings  our  observational  study  presents
ome  major  problems  which  limit  generalizability.  First,
he  evidence  of  persistent  inflammation  as  a potential  risk
or  chronic  CI  development  lacks  measurement  of  specific
nflammatory  cytokines.  Second,  immunological  assessment
as  not  been  investigated  in  our  population.  Third,  the
efinition  of  chronic  CI  as  applied  here  excludes  those
atients  with  persistent  signs  of  organ  dysfunction  (i.e.  renal
nsufficiency),  or  without  any  need  for  tracheostomy  and
rolonged  MV.
onclusions
atients  admitted  to  RICU  with  de  novo  ARF  frequently
rogress  to  chronic  CI,  infection-related  factors  being  cru-
ial  in  the  pathogenesis.  Data  here  presented  warrant
urther  research  to  clarify  all  the  potential  physio-
athological  factors  predisposing  patients  to  chronic  CI
evelopment.
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